AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,162,829 | -2.3% | 928,253 | -0.2% | 0.67% | +11.2% |
| Q2 2023 | $2,214,338 | +2.3% | 930,394 | -20.9% | 0.60% | -6.8% |
| Q1 2023 | $2,164,116 | -3.2% | 1,176,150 | 0.0% | 0.65% | +3.2% |
| Q4 2022 | $2,234,685 | +110.4% | 1,176,150 | +137.1% | 0.63% | +119.9% |
| Q3 2022 | $1,062,000 | -24.4% | 496,150 | 0.0% | 0.29% | -25.3% |
| Q2 2022 | $1,404,000 | -32.1% | 496,150 | 0.0% | 0.38% | -28.9% |
| Q1 2022 | $2,069,000 | +100.9% | 496,150 | +672.4% | 0.54% | +81.5% |
| Q2 2020 | $1,030,000 | -21.8% | 64,235 | -70.8% | 0.30% | -46.0% |
| Q1 2020 | $1,317,000 | -0.2% | 219,800 | +119.8% | 0.55% | +21.4% |
| Q4 2019 | $1,320,000 | +6.3% | 100,000 | 0.0% | 0.45% | -3.0% |
| Q3 2019 | $1,242,000 | -22.9% | 100,000 | 0.0% | 0.47% | -22.8% |
| Q2 2019 | $1,610,000 | – | 100,000 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,283,966 | $15,166,000 | 1.40% |
| Sio Capital Management, LLC | 591,870 | $3,930,000 | 0.98% |
| TFG Asset Management GP Ltd | 2,500,000 | $16,600,000 | 0.90% |
| Ikarian Capital, LLC | 1,356,048 | $9,004,000 | 0.73% |
| SABBY MANAGEMENT, LLC | 400,050 | $2,656,000 | 0.37% |
| Nantahala Capital Management | 1,793,500 | $11,909,000 | 0.34% |
| Regency Capital Management Inc.\DE | 57,000 | $378,000 | 0.29% |
| Eversept Partners, LP | 473,074 | $3,141,211 | 0.21% |
| MYDA Advisors LLC | 85,000 | $564,000 | 0.14% |
| Henry James International Management Inc. | 54,047 | $359,000 | 0.10% |